{
  "id": 2658,
  "url": "https://nnemf.org/research/2658-electromagnetic-wireless-remote-control-of-mammalian-transgene-expression",
  "title": "Electromagnetic wireless remote control of mammalian transgene expression",
  "authors": [
    "Lin Z, Guha Ray P, Huang J. et al."
  ],
  "journal": "Nature Nanotechnology",
  "year": "2025",
  "doi": "10.1038/s41565-025-01929-w",
  "pmid": null,
  "abstract": "Category: Nanotechnology, Biomedical Engineering Tags: electromagnetic fields, transgene expression, wireless control, nanotechnology, ROS, gene therapy, biosensors DOI: 10.1038/s41565-025-01929-w URL: https://www.nature.com/articles/s41565-025-01929-w Overview Communication between wireless field receivers and biological sensors remains a key constraint in the development of wireless electronic devices for minimally invasive medical monitoring and biomedical applications involving gene and cell therapies. Innovation This study describes a nanoparticle-cell interface that enables electromagnetic programming of wireless expression regulation (EMPOWER) of transgenes. This is achieved via the biosafe generation of cellular reactive oxygen species (ROS). - Multiferroic nanoparticles are coated with chitosan to improve biocompatibility. - These nanoparticles generate ROS in the cytoplasm of cells in response to a low-frequency (1-kHz) magnetic field. - Overexpressed ROS-responsive KEAP1/NRF2 biosensors detect the generated ROS and are connected to synthetic ROS-responsive promoters to drive transgene expression. Findings In a proof-of-concept study, subcutaneously implanted alginate-microencapsulated cells stably expressing an EMPOWER-controlled insulin expression system successfully normalized blood-glucose levels in a mouse model of type 1 diabetes in response to a weak magnetic field. Conclusion The research demonstrates a wireless and minimally invasive approach to regulate gene expression in vivo using electromagnetic fields, mediated by biocompatible nanoparticles and ROS-sensitive biosensors. This highlights a direct link between electromagnetic field exposure and physiological regulation at the molecular and cellular level, underscoring the potential health and therapeutic implications of EMF exposure.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Mouse model of type 1 diabetes (subcutaneously implanted alginate-microencapsulated cells)",
    "sampleSize": "—",
    "exposure": "ELF <1 MHz",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Multiferroic nanoparticles (chitosan-coated) generated cytoplasmic ROS in response to a low-frequency (1-kHz) magnetic field, which was detected by ROS-responsive KEAP1/NRF2 biosensors linked to synthetic promoters to drive transgene expression. In a proof-of-concept mouse model of type 1 diabetes, implanted cells with an EMPOWER-controlled insulin system normalized blood-glucose levels in response to a weak magnetic field.",
    "outcomes": [
      "Transgene expression regulation (insulin expression)",
      "Blood-glucose levels normalization",
      "Cellular reactive oxygen species (ROS) generation"
    ],
    "limitations": [
      "Sample size not reported in provided abstract/metadata",
      "Exposure intensity and duration not specified in provided abstract/metadata",
      "Proof-of-concept design",
      "generalizability beyond the described model not stated"
    ],
    "keywords": [
      "electromagnetic fields",
      "magnetic field",
      "1-kHz",
      "ELF",
      "wireless control",
      "transgene expression",
      "nanoparticles",
      "multiferroic nanoparticles",
      "chitosan",
      "reactive oxygen species",
      "ROS",
      "KEAP1",
      "NRF2",
      "biosensor",
      "synthetic promoter",
      "insulin",
      "type 1 diabetes",
      "mouse"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"other\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Mouse model of type 1 diabetes (subcutaneously implanted alginate-microencapsulated cells)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Transgene expression regulation (insulin expression)\",\n    \"Blood-glucose levels normalization\",\n    \"Cellular reactive oxygen species (ROS) generation\"\n  ],\n  \"main_findings\": \"Multiferroic nanoparticles (chitosan-coated) generated cytoplasmic ROS in response to a low-frequency (1-kHz) magnetic field, which was detected by ROS-responsive KEAP1/NRF2 biosensors linked to synthetic promoters to drive transgene expression. In a proof-of-concept mouse model of type 1 diabetes, implanted cells with an EMPOWER-controlled insulin system normalized blood-glucose levels in response to a weak magnetic field.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Sample size not reported in provided abstract/metadata\",\n    \"Exposure intensity and duration not specified in provided abstract/metadata\",\n    \"Proof-of-concept design; generalizability beyond the described model not stated\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"electromagnetic fields\",\n    \"magnetic field\",\n    \"1-kHz\",\n    \"ELF\",\n    \"wireless control\",\n    \"transgene expression\",\n    \"nanoparticles\",\n    \"multiferroic nanoparticles\",\n    \"chitosan\",\n    \"reactive oxygen species\",\n    \"ROS\",\n    \"KEAP1\",\n    \"NRF2\",\n    \"biosensor\",\n    \"synthetic promoter\",\n    \"insulin\",\n    \"type 1 diabetes\",\n    \"mouse\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"other\",\n      \"weight\": 0.4,\n      \"reason\": \"Biomedical/therapeutic use of low-frequency magnetic fields to control gene expression via nanoparticles; no specific portal hub provided in prompt matches this topic.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://www.nature.com/articles/s41565-025-01929-w",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=2658",
  "updated": "2026-02-12 19:23:39"
}